Help Wanted for the Quest!
Completed: 0%
Quest hub:
Screening, detection, diagnosis, and monitoring of Cancer. Striving for early, accurate, safe and cost effective methods.
Welcome new Heroes (including all user testers)!
Visitors, explore and click the tabs from DATA to EVENTS (scroll left on mobile)
What is our purpose with this Quest?
- To create agile, interactive, and complete overviews and roadmaps of the science and technologies driving progress on early, accurate, safe, easy, and cost effective Cancer screening and diagnostic methods, and then help accelerate that progress
How?
- The publicly available databases and roadmaps we create as a community help align all entities working on solutions and identify where to focus efforts and resources for maximum impact
- Enable anyone, even non-technical people, to take action on this disease with science, technology, and innovation via our tasks
- Provide an open source pre-projecting platform to nurture ideas and breed innovation for new and improved solutions
- This all leads to making the most of our global resources, collaboration, and impact to accelerate progress on the ideal solutions
Want to help?
- Become a Hero and JOIN NOW (is free, takes 5-10 minutes here and there to do digital volunteering Tasks)
- Spread the word: follow, like, tag, share! Insta LinkedIn FB Twitter YouTube
- Show some love with donations via our Support page
Volunteering Heroes, go take action with a Task, be vocal in the Labs, or post in the newsfeed!
Current Quest objective: Let's find 21 EVENTS this year (objective ends February 5, 2021)
Expand the "Completed:" progress bar above for more details on how to help with this
Read our Quest community written article on...
Check out our intro and overview...
Quest leaderboard
May 26, 2021
A Ludwig Cancer Research study has discovered how to revive a powerful but functionally inert subset of anti-cancer immune cells that are often found within tumors for cancer therapy.
May 26, 2021
A new technology developed by University of Zurich researchers enables the body to produce therapeutic agents on demand at the exact location where they are needed. The innovation could reduce the side effects of cancer therapy and may hold the solution to better delivery of Covid-related therapies
May 25, 2021
Development of AI medical imaging, new biomarkers, electrochemical immunosensors, and molecular diagnostic approaches are leading the way for advances in screening and diagnosing breast cancer.
May 18, 2021
An introduction to these common cancers and look into advances like with improved imaging using low dose radiation x-ray technology, accessing tissues via ultrasound and optics, using liquid biopsies to measure ctDNA (tumor-derived fragmented DNA in the bloodstream), and AI powered diagnostics.
May 11, 2021
Colorectal cancer contributes to 9.7% of the global cancer incidence. Current diagnosis is via colonoscopy imaging and screening is done by checking stool samples for blood and more recently early diagnosis biomarkers that are still in development.
Apr 07, 2021
ISET® technology makes Circulating Tumor Cells accessible to target PDAC mutant genes detection in pancreatic cancer with an accuracy demonstrated by a targeted scNGS
Mar 02, 2021
COVID-19 vaccines may give false positives in breast cancer screenings
Feb 10, 2021
The illuminating new “light pollution” study was published Monday in the American Cancer Society journal, Cancer.
Feb 10, 2021
When treating cancer, researchers are always searching for ways to remove cancer cells while minimizing damage to the rest of the body. One possible approach is to find processes unique to cancer cells, and which would allow specific targeting. If such a process can be disrupted, only those cells would be affected. Professor Tomer Shlomi’s research group discovered such a process.
Feb 10, 2021
Targeting and changing autophagy, otherwise known as cell recycling, has been linked to helping control or diminish certain cancers. Now, University of Cincinnati researchers have shown that completely halting this process in a very aggressive form of breast cancer may improve outcomes for patients one day.
Jan 31, 2021
Cancer screenings have dropped between 86% and 94% in preventive cancer screenings nationwide, compared to 2017 to 2019.
Jan 29, 2021
Gene mutations associated with breast cancer even in women who do not have a history of the disease offer a new way of estimating risk and may lead to future changes screening and management.